We are 213,316 members in 82 forums discussing 152,270 topics.

Help with Abbreviations

Topic: Breaking Research News from Breastcancer.org

Forum: Clinical Trials, Research News, Podcasts, Study Results —

Share your research articles, interpretations and experiences here. Let us know how these studies affect you and your decisions.

Posted on: Apr 16, 2012 11:33AM - edited Jan 16, 2016 01:28PM by Moderators

Moderators wrote:

Breastcancer.org strives to bring you updates on the latest breast cancer research through its Research News program. Medical experts at Breastcancer.org provide easy-to-understand summaries of what the research means for YOU.

Check out this thread on a regular basis to see all the breaking news about current breast cancer research from our experts.

Get Personalized Research News Stories JUST for You!
Don't forget to fill out your profile: In the top right hand corner of the screen, under My Profile, you'll find My Diagnoses and My Treatments. Once you've provided enough information, we'll send recommended articles. Members can save these articles for later, or archive them when they're finished with them.

If you would like to receive Personalized Research News articles, based on diagnosis and treatment information, you'll need to go into "My Profile" and under the "Recommended Articles", click "turn on".

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Page 31 of 31 (925 results)

Posts 901 - 925 (925 total)

Log in to post a reply

Sep 27, 2018 11:56AM Moderators wrote:

MRI Twice per Year May Be Better Than Annual Mammogram for Finding Early Breast Cancers in High-Risk Women
September 17, 2018

A study suggests that breast cancer screening with MRI twice per year is better than one mammogram per year for finding breast cancer early in young women with a high risk of breast cancer. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Oct 1, 2018 10:33PM Chemokaze wrote:

Hmmmm....so is there a study for women without genetic mutations that show the benefit of Breast MRI as a screening tool for early breast cancer? Surely, there is since only 5-10% of women dx with breast cancer have genetic mutation, but 1 in 8 women will develop breast cancer in their lifetime

10/2018: NEAD; 7/2018: Onward to Verzenio, Zometa, Faslodex, & CyberKnife to single met to L4 spine. Dx 9/1996, IDC, Left, Stage IB, Grade 3, 0/21 nodes, ER+/PR+ Dx 5/2016, IDC, Right, Stage IIIC, Grade 2, 14/21 nodes, ER+/PR+, HER2- Dx 6/2018, Stage IV, metastasized to bone
Log in to post a reply

Oct 5, 2018 02:58PM Moderators wrote:

Hi Chemokaze,

There are numerous Research News articles on the main Breastcancer.org site about Breast MRI that may help answer your question!

--The Mods

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Oct 5, 2018 03:00PM Moderators wrote:

Does Processed Meat Increase Breast Cancer Risk?
October 5, 2018

A study suggests that eating processed meat is linked to a higher risk of breast cancer. Still, the study leaves many questions unanswered, and the researchers do not suggest that people stop eating processed meats. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Oct 11, 2018 10:59AM Moderators wrote:

Study Shows Value of Second Opinions for Breast Cancer Diagnosis
October 5, 2018

A study strongly suggests that a second opinion can be very valuable for people diagnosed with breast cancer: more than 40% of people who asked for a second opinion had a change in diagnosis. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Oct 11, 2018 11:00AM Moderators wrote:

Silicone Breast Implants Linked to Number of Complications, but FDA Critical of Study
October 5, 2018

A study suggests that silicone breast implants are associated with a higher risk of certain autoimmune disorders, as well as stillbirth and melanoma, but the FDA disagrees with the results. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Oct 11, 2018 11:01AM Moderators wrote:

Black Women, Women Living in Poverty Less Likely to Recognize Barriers to Breast Cancer Screening, So They Don't Take Advantage of Patient Navigation for Optimal Care
October 9, 2018

Women who need patient navigation interventions the most are less likely to report barriers to optimal breast cancer screening care. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Oct 19, 2018 01:05PM Moderators wrote:

Chemo Brain in Older Women May Be Linked to Specific Version of APOE Gene
October 11, 2018

Older women treated with chemotherapy and/or hormonal therapy had poorer cognitive skills compared to similar women who hadn't been diagnosed with breast cancer; women with the APOEe4 gene had the poorest post-treatment cognitive skills. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Oct 19, 2018 01:06PM - edited Oct 19, 2018 01:07PM by Moderators

FDA Approves Talzenna to Treat Metastatic Breast Cancer in Women With BRCA Mutations
October 17, 2018

The FDA has approved Talzenna (chemical name: talazoparib) to treat locally advanced or metastatic HER2-negative breast cancer in women with an inherited BRCA1 or BRCA2 mutation. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Oct 23, 2018 12:45PM Moderators wrote:

Black Women Less Likely to Take Hormonal Therapy as Prescribed After Surgery for Breast Cancer
October 22, 2018

Compared to white women, black women diagnosed with early-stage, hormone-receptor-positive disease are less likely to take hormonal therapy every day, as prescribed, or to stop taking the medicine early. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Oct 30, 2018 11:46AM Moderators wrote:

Immunotherapy Tecentriq Helps Treat Certain Advanced-Stage Triple-Negative Breast Cancers
October 24, 2018

Tecentriq, an immunotherapy medicine, combined with the targeted therapy Abraxane was better than Abraxane alone for people diagnosed with locally advanced or metastatic triple-negative breast cancer who had not been treated yet for advanced-stage disease. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Oct 30, 2018 11:47AM Moderators wrote:

Adding Ibrance to Faslodex Improves Overall Survival in Advanced-Stage, Hormone-Receptor-Positive Breast Cancer
October 24, 2018

Latest results from the PALOMA-3 trial show adding Ibrance to Faslodex improves overall survival by about 7 months compared to Faslodex alone in women diagnosed with hormone-receptor-positive, HER2-negative advanced-stage breast cancer that had grown while being treated with hormonal therapy. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Oct 30, 2018 11:48AM Moderators wrote:

Is 9 Weeks of Herceptin as Good as 1 Year of Herceptin?
October 29. 2018

While 9 weeks of Herceptin was associated with fewer heart problems compared to 1 year of Herceptin, the difference in disease-free survival was small and the researchers said 1 year of Herceptin should remain the standard of care. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Oct 30, 2018 03:05PM Moderators wrote:

Breast Cancer Risk Assessment Tool Seems Accurate for 19 Years
October 29, 2018

A study has found that the Tyrer-Cuzick breast cancer risk assessment tool is accurate for at least 19 years. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Nov 1, 2018 12:56PM Moderators wrote:

Mastectomy Doesn't Eliminate Need for Mammograms
October 30, 2018

Having a single or double mastectomy doesn't completely eliminate the need for breast imaging in the future. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Nov 1, 2018 01:02PM Moderators wrote:

Many Women Report Paying Out-of-Pocket Costs for Routine Mammograms
October 30, 2018

More than 23% of women aged 50 to 64 and nearly 12% of women aged 65 to 74 reported paying a cost for their most recent mammogram. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Nov 1, 2018 01:03PM Moderators wrote:

Women With Metastatic Breast Cancer Report "Catastrophic" Financial Effects
October 31, 2018

A national survey of more than 1,000 women diagnosed with metastatic breast cancer found that 35% had no insurance and nearly 70% said they were worried about financial problems because of cancer. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Nov 7, 2018 11:57AM Moderators wrote:

Long-Term Results Suggest Fat Grafting Does Not Increase Recurrence Risk
October 31, 2018

A study suggests fat grafting breast reconstruction does not increase the risk of breast cancer recurrence compared to more traditional reconstruction techniques. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Nov 7, 2018 12:03PM Moderators wrote:

Many Younger Women Don't Take Tamoxifen as Prescribed for Breast Cancer
November 1, 2018

The first study to look at adherence to hormonal therapy among younger women found that more than 18% were not taking the medicine as prescribed. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Nov 7, 2018 12:06PM Moderators wrote:

Radiation Therapy After Surgery for Low-Risk DCIS Reduces Recurrence Risk
November 1, 2018

Radiation therapy after lumpectomy to remove low-risk DCIS reduces the risk of recurrence, but had no effect on overall survival. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Nov 7, 2018 12:09PM Moderators wrote:

No Increase in Long-Term Side Effects With Weekly Hypofractionated Radiation Schedule
November 2, 2018

After lumpectomy for early-stage breast cancer, an accelerated radiation therapy schedule of treatment once per week for 5 weeks offers about the same rate of long-term side effects as a traditional schedule of daily treatment for 5 weeks. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Nov 7, 2018 12:10PM Moderators wrote:

No Increase in Long-Term Side Effects With Weekly Hypofractionated Radiation Schedule
November 2, 2018

After lumpectomy for early-stage breast cancer, an accelerated radiation therapy schedule of treatment once per week for 5 weeks offers about the same rate of long-term side effects as a traditional schedule of daily treatment for 5 weeks. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Nov 7, 2018 12:11PM Moderators wrote:

Experimental Alpelisib May Help Treat Advanced-Stage, Hormone-Receptor-Positive, HER2-Negative Breast Cancer With Specific Mutation
November 6, 2018

Experimental alpelisib combined with Faslodex improved progression-free survival more than Faslodex alone in people diagnosed with advanced-stage, hormone-receptor-positive, HER2-negative breast cancer with a PIK3CA mutation. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Nov 15, 2018 11:13AM Moderators wrote:

Zoladex Helps Preserve Fertility in Women With Early-Stage, Hormone-Receptor-Negative Breast Cancer Treated With Chemotherapy
November 9, 2018

Five-year results found women diagnosed with early-stage, hormone-receptor-negative breast cancer who were treated with Zoladex in addition to chemotherapy before surgery were much less likely to be infertile after chemotherapy ended. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Nov 15, 2018 11:16AM Moderators wrote:

Zometa Plus Femara Seems Better Than Tamoxifen for Premenopausal Women With Hormone-Receptor-Positive Breast Cancer, but Causes More Side Effects
November 13, 2018

The combination of Zometa and Femara after surgery offered better disease-free survival than tamoxifen for premenopausal women diagnosed with early-stage, hormone-receptor-positive breast cancer, but caused more side effects. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...

Page 31 of 31 (925 results)